Education
About Us
Working with TipRanks
Follow Us
Leonard Fritzel Eugene Insider Profile
4 Followers
Leonard Fritzel Eugene, Director at Voyageur Pharmaceuticals, holds 32.25K shares in Voyageur Pharmaceuticals (Ticker: VYYRF). Most recently, Leonard Fritzel Eugene Bought $32,250 shares of Voyageur Pharmaceuticals on Jul 01, 2025 for an estimated value of 10.96K.
Leonard Fritzel Eugene has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Leonard Fritzel Eugene's holdings
Insider Roles
Director
Roles that Leonard Fritzel Eugene holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Leonard Fritzel Eugene
Leonard Fritzel Eugene's Trading History
List of latest transactions for each holding click on a transaction to see Leonard Fritzel Eugene's performance on stock
You May Also Like
Leonard Fritzel Eugene insider profile FAQ
What is the percentage of profitable transactions made by Leonard Fritzel Eugene?
The percentage of profitable transactions made by Leonard Fritzel Eugene is ―.
What is the average return per transaction made by Leonard Fritzel Eugene?
The average return per transaction made by Leonard Fritzel Eugene is ―.
What stocks does Leonard Fritzel Eugene hold?
Leonard Fritzel Eugene holds: VYYRF stocks.
What was Leonard Fritzel Eugene’s latest transaction?
Leonard Fritzel Eugene latest transaction was an Informative Buy of $10.96K.
What was Leonard Fritzel Eugene's most profitable transaction?
Leonard Fritzel Eugene’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Leonard Fritzel Eugene's role in Voyageur Pharmaceuticals?
Leonard Fritzel Eugene's role in Voyageur Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.